anti-cancer vaccines

Kolon Pharma, the pharmaceutical affiliate of South Korea's Kolon Group, is merging with anti-cancer drug developer Platbio to advance the developme...

South Korea's pharmaceutical firm GC Biopharma Corp. said on Monday that it has won a $44.3 million (57.9 billion won) order for flu vaccines in a d...

South Korean medical AI company Lunit said on Monday that its 3D breast tomosynthesis artificial intelligence (AI) image analysis solution, "Lunit I...

Prestige Biopharma, a biopharmaceutical company in South Korea, announced on Thursday that their pancreatic cancer antibody drug, PBP1510 (Ulenistam...

Noroo Paint, in collaboration with GS Engineering & Construction Co., announced on Tuesday the development of "Qfit Protect," a high-performance...

South Korea's pharmaceutical firm GC Biopharma Corp. announced on Monday that its quadrivalent flu vaccine has received marketing approval from the ...

South Korea's GC Biopharma Corp. announced on Thursday that it will start developing a flu vaccine based on messenger ribonucleic acid (mRNA).The dr...

SK Bioscience Co., a leading South Korean vaccine and biotech company, announced on Monday that its phase 3 clinical trial plan for a heterogeneous ...

SKC, the chemical materials unit of South Korea's second-largest conglomerate, announced on Thursday that it has received the ISO 37001 certificatio...

South Korea's biopharmaceutical company Celltrion Inc. will develop an anti-cancer drug that combines oncolytic virus technology with biosimilars un...

SillaJen Inc. said on Monday it has enrolled the first patient in a US phase 1 trial of an anti-cancer drug BAL0891 licensed from Swiss drugmaker Ba...

South Korea's biopharmaceutical company EuBiologics Co. announced on Wednesday that its meningococcal pentavalent conjugate vaccine EuMCV5 under dev...

South Korea's GC Biopharma Corp. is set to regain the No. 1 spot in global production of chickenpox vaccines after earning qualification to enter th...

Vaxcell-Bio Therapeutics, a South Korean company specializing in anti-cancer immunotherapy, announced on Wednesday its partnership with Cellid Co. t...

GC Biopharma Co. (formerly Green Cross Corp.) said on Monday it has entered into a joint sales partnership with Sanofi-Aventis Korea, the South Kore...

GC Biopharma Co.'s production facility in Ochang (North Chungcheong Province) secured a pre-qualification (PQ) certification from the World Health O...

South Korea's defense contractor LIG Nex1 Co. will join hands with ROMARM, a Romanian state-run defense company, to develop anti-aircraft missiles a...

South Korean medical AI company Lunit has supplied its breast cancer imaging analysis solution — Agfa HealthCare Enterprise Imaging — to...

InnoGene, which is seeking to be listed on the Kosdaq market at the end of this month, said on Wednesday that it has confirmed its offering price at...

Studies have shown that South Korea's hongsam (red ginseng) is effective in preventing respiratory diseases such as the flu and pneumonia.The Korean...

South Korean pharmaceutical company Boryung announced that its production facility for anti-cancer injections in Yesan, South Chungcheong Province, ...

Prestige Biopharma, a Singapore-based biopharmaceutical company with operations in South Korea and the US,  has applied to the Australian clini...

South Korean medical diagnostic company NGeneBio Co. has partnered with MP Group, a large consignment testing agency in Thailand, to launch a precis...

SK Bioscience Co., a bio and pharmaceutical affiliate of South Korea's SK Group, announced on Thursday that its world-first cell culture-based quadr...

A research team at South Korea's top science and technology university has developed an anti-drone technology that can remotely neutralize a city-in...

South Korea's biotech companies Bridge Biotherapeutics Inc. and Pinotbio on Thursday said they will jointly develop new antibody-drug conjugates (AD...

Celltrion Healthcare Co. Ltd. said on Thursday that it launched Vegzelma, a biosimilar to the anti-cancer drug Avastin (active ingredient: bevacizum...

LG Chem Ltd. is set to complete its $571 million purchase of the US biotech firm AVEO Pharmaceuticals Inc. on Friday, which would strengthen its ant...

South Korean biotech company MedPacto Inc. ’s Vactosertib monotherapy for osteosarcoma patients has been designated as a fast-track developmen...

Prestige Biopharma Korea said on Tuesday that it has obtained a domestic patent for the CTHRC1 neutralizing antibody of the drug candidate PBP1710. ...